CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Completed · Not applicable
Conditions studied: Prostate Cancer, Prostatic Cancer, Prostatic Neoplasms, Prostate Neoplasms, Cancer of the Prostate
In brief
The purpose of this study is to investigate the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer and to evaluate the effects of this treatment on the quality of life over time.
Key facts
- Study ID
- NCT00643617
- Run by
- Accuray Incorporated
- People needed
- 307
- Starts
- 2007-10-22
- Expected to finish
- 2022-04-07
- Last updated by the study team
- 2023-05-09
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Patient must be at least 18 years of age
- Histologically proven prostate adenocarcinoma
- Biopsy within 1 year of date of registration
- Clinical Stage (CS) T1b-T2b, N0, M0
- Patients belonging to one of the following risk categories:
- Low Risk: CS T1b-T2a, Gleason Score 2-6, Prostate Specific Antigen (PSA) < or = 10 ng/ml
- Intermediate Risk: CS T2b, Gleason Score 2-6, PSA < or = 10 ng/ml or CS T1b-T2b, Gleason Score 2-6, PSA < or = 20 ng/ml or CS T1b-T2b, Gleason Score 7 and PSA < or = 10 ng/ml
- Eastern Cooperative Oncology Group (ECOG) performance status 0-1
You may not qualify if…
- Clinical Stage T2c or greater
- Prior prostatectomy or cryotherapy of the prostate
- Prior radiotherapy of the prostate or lower pelvis
- Implanted hardware or other material that would prohibit appropriate treatment planning or delivery
- History of an invasive malignancy other than basal or squamous skin cancers in the last 5 years
- Hormone ablation for two months prior to enrollment or during treatment
Where it is running
- Mitchell Cancer Center University of South Alabama — Mobile, Alabama, United States
- Community Regional Medical Center — Fresno, California, United States
- Long Beach Memorial Medical Center — Long Beach, California, United States
- Pasadena Cyberknife Center — Pasadena, California, United States
- CyberKnife Centers of San Diego — San Diego, California, United States
- Penrose Cancer Center — Colorado Springs, Colorado, United States
- Colorado Cyberknife — Lafayette, Colorado, United States
- New Millenium CyberKnife — Brandon, Florida, United States
- JFK Comprehensive Cancer Center — Lake Worth, Florida, United States
- South Florida Radiation Oncology — Wellington, Florida, United States
- Elmhurst Memorial Hospital — Elmhurst, Illinois, United States
- Benefis Health System - Sletten Cancer Institute — Great Falls, Montana, United States
- Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada, United States
- AtlantiCare Regional Medical Center — Egg Harbor, New Jersey, United States
- University of North Carolina — Chapel Hill, North Carolina, United States
- St. Anthony Hospital — Oklahoma City, Oklahoma, United States
- Sarah Cannon Research Institute — Nashville, Tennessee, United States
- East Texas Medical Center — Tyler, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.